BioCryst製藥所有資訊

BioCryst製藥 | 4：持股變動聲明-高管 Thackray Helen M.

04/03 04:27

BioCryst製藥 | 4：持股變動聲明-董事 MILANO VINCENT

03/05 06:51

BioCryst製藥 | 4：持股變動聲明-董事 HEGGIE THERESA

03/05 05:36

BioCryst製藥 | SC 13G/A：超過5%持股股東披露文件(修正)-Felix J. Baker(4.98%),Julian C. Baker(4.98%)等

02/15 06:47

BioCryst製藥 | SC 13G：超過5%持股股東披露文件-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)

02/14 22:07

BioCryst製藥 | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(8.67%)

02/14 07:08

BioCryst製藥 | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.1%)

01/25 06:32

BioCryst製藥 | SC 13G/A：超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(6.24%)

01/25 02:10

BioCryst製藥 | 4：持股變動聲明-高管 Stonehouse Jon P

01/04 13:00

BioCryst製藥 | 4：持股變動聲明-高管 Thackray Helen M.

2023/12/21 05:42

BioCryst製藥 | 4：持股變動聲明-高管 Stonehouse Jon P

2023/12/21 05:40

BioCryst製藥 | 4：持股變動聲明-首席商務官 Gayer Charles K

2023/12/21 05:38

BioCryst製藥 | 4：持股變動聲明-首席財務官 Doyle Anthony

2023/12/21 05:35

BioCryst製藥 | 4：持股變動聲明-首席法務官 Barnes Alane P

2023/12/21 05:33

BioCryst製藥 | 4：持股變動聲明-高管 Thackray Helen M.

2023/12/19 05:47

BioCryst製藥 | 4：持股變動聲明-高管 Stonehouse Jon P

2023/12/19 05:43

BioCryst製藥 | 4：持股變動聲明-首席商務官 Gayer Charles K

2023/12/19 05:40

BioCryst製藥 | 4：持股變動聲明-首席財務官 Doyle Anthony

2023/12/19 05:37

BioCryst製藥 | 4：持股變動聲明-首席法務官 Barnes Alane P

2023/12/19 05:34

BioCryst製藥 | 4：持股變動聲明-董事 MILANO VINCENT

2023/12/02 05:42